Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: A correlative study of tumor subtypes

International Journal of Surgical Pathology

Volumn 18, Issue 1, 2010, Pages 5-13

  Salehi, Fateme ^a   Kovacs, Kalman ^a   Scheithauer, Bernd W ^b   Cantelmi, David ^a   Horvath, Eva ^a   Lloyd, Ricardo V ^b   Cusimano, Michael ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

GH; Lactotroph adenoma; Pituitary adenomas; PTTG; Somatotroph adenoma

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; OCTREOTIDE; PROLACTIN; SECURIN; SOMATOSTATIN;

ACTH SECRETING ADENOMA; ARTICLE; CANCER MORPHOLOGY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GONADOTROPH ADENOMA; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROLACTINOMA; STAINING;

ANTINEOPLASTIC AGENTS, HORMONAL; BROMOCRIPTINE; HORMONE ANTAGONISTS; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; OCTREOTIDE; PITUITARY NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 76649132319     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896909356105     Document Type: Article

References (52)

1. Pei L., Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 1997 ; 11: 433-441.
2. Zou H., McGarry TJ, Bernal T., Kirschner MW Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science. 1999 ; 285: 418-422.
3. Boelaert K., McCabe CJ, Tannahill LA, et al. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrinol Metab. 2003 ; 88: 2341-2347.
4. Heaney AP, Nelson V., Fernando M., Horwitz G. Transforming events in thyroid tumorigenesis and their association with follicular lesions. J Clin Endocrinol Metab. 2001 ; 86: 5025-5032.
5. Hamid T., Kakar SS PTTG/securin activates expression of p53 and modulates its function. Mol Cancer. 2004 ; 3: 18.
6. Kim DS, Franklyn JA, Stratford AL, et al. Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer. J Clin Endocrinol Metab. 2006 ; 91: 1119-1128.
7. Tfelt-Hansen J., Kanuparthi D., Chattopadhyay N. The emerging role of pituitary tumor transforming gene in tumorigenesis. Clin Med Res. 2006 ; 4: 130-137.
8. Zhang X., Horwitz GA, Prezant TR, et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 1999 ; 13: 156-166. (Pubitemid 29022288)
9. Akino K., Mineta T., Fukui M., Fujii T., Akita S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen. 2003 ; 11: 354-360.
10. Rajamannan NM, Subramaniam M., Abraham TP, et al. TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: discovery and characterization of a novel signaling pathway. J Cell Biochem. 2007 ; 100: 315-325.
11. Chesnokova V., Zonis S., Rubinek T., et al. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res. 2007 ; 67: 10564-10572.
12. Donangelo I., Gutman S., Horvath E., et al. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology. 2006 ; 147: 4781-4791.
13. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: World Health Organization Classification of Tumours ; 2004.
14. Salehi F., Kovacs K., Scheithauer BW, Lloyd RV, Cusimano M. Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update. Endocr Relat Cancer. 2008 ; 15: 721-743.
15. Hunter JA, Skelly RH, Aylwin SJ, et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol. 2003 ; 148: 203-211.
16. Abbud RA, Takumi I., Barker EM, et al. Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol. 2005 ; 19: 1383-1391.
17. Uccella S., Tibiletti MG, Bernasconi B., Finzi G., Oldrini R., Capella C. Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas. Anal Quant Cytol Histol. 2005 ; 27: 241-252.
18. Tanaka C., Kimura T., Yang P., et al. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. J Clin Endocrinol Metab. 1998 ; 83: 2631-2634.
19. Kontogeorgos G., Kapranos N., Orphanidis G., Rologis D., Kokka E. Molecular cytogenetics of chromosome 11 in pituitary adenomas: a comparison of fluorescence in situ hybridization and DNA ploidy study. Hum Pathol. 1999 ; 30: 1377-1382.
20. Finelli P., Giardino D., Rizzi N., et al. Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study. Int J Cancer. 2000 ; 86: 344-350.
21. Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer. 2001 ; 1: 109-117.
22. Wang Z., Yu R., Melmed S. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol. 2001 ; 15: 1870-1879.
23. Kim DS, Franklyn JA, Smith VE, et al. Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis. 2007 ; 28: 749-759.
24. Kim D., Pemberton H., Stratford AL, et al. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells. Oncogene. 2005 ; 24: 4861-4866.
25. Horwitz GA, Miklovsky I., Heaney AP, Ren SG, Melmed S. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression. Mol Endocrinol. 2003 ; 17: 600-609.
26. Minematsu T., Suzuki M., Sanno N., Takekoshi S., Teramoto A., Osamura RY PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocr Pathol. 2006 ; 17: 143-153.
27. Friend KE, Chiou YK, Laws ER Jr, Lopes MB, Shupnik MA Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab. 1993 ; 77: 1281-1286.
28. Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab. 1993 ; 77: 1275-1280.
29. Pellegrini I., Barlier A., Gunz G., et al. Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab. 1994 ; 79: 189-196.
30. Asa SL, Ezzat S. Molecular basis of pituitary development and cytogenesis. Front Horm Res. 2004 ; 32: 1-19.
31. Yin H., Fujimoto N., Maruyama S., Asano K. Strain difference in regulation of pituitary tumor transforming gene (PTTG) in estrogen-induced pituitary tumorigenesis in rats. Jpn J Cancer Res. 2001 ; 92: 1034-1040.
32. Heaney AP, Horwitz GA, Wang Z., Singson R., Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med. 1999 ; 5: 1317-1321.
33. Kovacs K., Horvath E. Effects of medical therapy on pituitary tumors. Ultrastruct Pathol. 2005 ; 29: 163-167.
34. Florio T., Morini M., Villa V., et al. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology. 2003 ; 144: 1574-1584.
35. Hubina E., Nanzer AM, Hanson MR, et al. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur J Endocrinol. 2006 ; 155: 371-379.
36. Renner U., Mojto J., Lange M., Muller OA, von Werder K., Stalla GK Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro. Eur J Endocrinol. 1994 ; 130: 80-91.
37. Vlotides G., Cruz-Soto M., Rubinek T., Eigler T., Auernhammer CJ, Melmed S. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells. Mol Endocrinol. 2006 ; 20: 3321-3335.
38. Stefaneanu L., Kovacs K., Scheithauer BW, et al. Effect of dopamine agonists on lactotroph adenomas of the human pituitary. Endocr Pathol. 2000 ; 11: 341-352.
39. Mu YM, Oba K., Yanase T., et al. Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21(WAF1/CIP1). Endocr J. 2003 ; 50: 771-781.
40. Yu R., Cruz-Soto M., Li Calzi S., Hui H., Melmed S. Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. J Endocrinol. 2006 ; 191: 45-53.
41. Kim DS, Franklyn JA, Boelaert K., Eggo MC, Watkinson JC, McCabe CJ Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. J Clin Endocrinol Metab. 2006 ; 91: 4603-4611.
42. Saez C., Japon MA, Ramos-Morales F., et al. hpttg Is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene. 1999 ; 18: 5473-5476.
43. Minematsu T., Egashira N., Kajiya H., et al. PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. Endocr Pathol. 2007 ; 18: 8-15.
44. Boelaert K., Tannahill LA, Bulmer JN, et al. A potential role for PTTG/securin in the developing human fetal brain. FASEB J. 2003 ; 17: 1631-1639.
45. Boelaert K., Yu R., Tannahill LA, et al. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro. J Mol Endocrinol. 2004 ; 33: 663-677.
46. Kim DS, Buchanan MA, Stratford AL, et al. PTTG promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid cancer. Clin Otolaryngol. 2006 ; 31: 246.
47. Zhou C., Liu S., Zhou X., et al. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer. 2005 ; 113: 891-898.
48. McCabe CJ, Khaira JS, Boelaert K., et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf). 2003 ; 58: 141-150.
49. Zhang X., Horwitz GA, Heaney AP, et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab. 1999 ; 84: 761-767. (Pubitemid 29075718)
50. Wierinckx A., Auger C., Devauchelle P., et al. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer. 2007 ; 14: 887-900.
51. Kilkenny DM, Hill DJ Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrinology. 1996 ; 137: 5078-5089.
52. Murakami M., Das S., Kim YJ, Cho W., Kudo I. Perinuclear localization of cytosolic phospholipase A(2)alpha is important but not obligatory for coupling with cyclooxygenases. FEBS Lett. 2003 ; 546: 251-256.